Improvement of bone metabolism after infliximab therapy in Crohn's disease

被引：0
|
作者：
Miheller, P
Muzes, G
Zagoni, T
Toth, M
Tulassay, Z
机构：
来源：
GASTROENTEROLOGY | 2004年 / 126卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A470 / A471
页数：2
相关论文
共 50 条
  • [21] Anorectal carcinoma after infliximab therapy in Crohn's disease: Report of a case
    Melichar, Bohuslav
    Bures, Jan
    Dedic, Karel
    DISEASES OF THE COLON & RECTUM, 2006, 49 (08) : 1228 - 1233
  • [22] Changes of OPG and RANKL concentrations in Crohn's disease after infliximab therapy
    Miheller, Pal
    Muezes, Gyoergyi
    Racz, Karoly
    Blazovits, Anna
    Lakatos, Peter
    Herszenyi, Laszlo
    Tulassay, Zsolt
    INFLAMMATORY BOWEL DISEASES, 2007, 13 (11) : 1379 - 1384
  • [23] Acute coronary syndrome after infliximab therapy in a patient with Crohn’s disease
    Vasilios Panteris
    Anna Perdiou
    Vasilios Tsirimpis
    Demetrios Georgios Karamanolis
    World Journal of Gastroenterology, 2006, (38) : 6235 - 6238
  • [24] Demyelination-like syndrome in Crohn's disease after infliximab therapy
    Freeman, HJ
    Flak, B
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 19 (05): : 313 - 316
  • [25] Neurological symptoms suggestive of demyelination in Crohn's disease after infliximab therapy
    Dubcenco, Elena
    Ottaway, Clifford A.
    Chen, Dean L.
    Baker, Jeffrey P.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2006, 18 (05) : 565 - 566
  • [26] Large Bowel Progressive Stricture after Infliximab Therapy for Crohn's Disease
    Matsueda, Katsunori
    Toyokawa, Tatsuya
    Sakata, Masahiro
    Fujita, Isao
    Horii, Jouichiro
    INTERNAL MEDICINE, 2018, 57 (15) : 2179 - 2183
  • [27] INFLIXIMAB INDUCTION COURSE CAN ACTIVATE BONE METABOLISM IN SEVERE PEDIATRIC CROHN'S DISEASE
    Gabrusskaia, T.
    Kostik, M.
    Revnova, M.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S420 - S420
  • [28] Improvement in a biomarker of bone formation during infliximab therapy in pediatric Crohn disease: Results of the REACH study
    Thayu, M.
    Leonard, M.
    Hyams, J.
    Crandall, W.
    Kugathasan, S.
    Otley, A.
    Olsen, A.
    Xu, S.
    Marano, C.
    Heuschke, R.
    Veereman-Routers, G.
    Griffiths, A.
    Baldassano, R.
    BONE, 2007, 40 (06) : S81 - S81
  • [29] Infliximab therapy for Crohn's disease anoperineal lesions
    Ouraghi, A
    Nieuviarts, S
    Mougenel, JL
    Allez, M
    Barthet, M
    Carbonnel, F
    Cosnes, J
    Gendre, JP
    Flourié, B
    Meurisse, JJ
    Quandalle, P
    Ernst, O
    Lemann, M
    Cortot, A
    Modigliani, R
    Colombel, JF
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2001, 25 (11): : 949 - 956
  • [30] Infliximab maintenance therapy for fistulizing Crohn's disease
    Brechmann, T
    MEDIZINISCHE KLINIK, 2006, 101 (05) : 423 - 424
12345